Novo Nordisk has terminated its partnership with Hims & Hers Health due to allegations of the telehealth company selling counterfeit versions of its weight-loss drug, Wegovy, which posed safety risks to patients. This decision follows a recent collaboration intended to enhance accessibility to obesity treatments, with Hims & Hers shares dropping by approximately 31% after the announcement.
Need More Context? 🔎
Ultra-processed foods make up the majority of kids’ diet, CDC report finds
Ultra-processed foods constitute 62% of children's and teens' daily calories and 53% for adults, as reported by the CDC, marking the first estimates of their prevalence in American diets. This report has led to discussions on regulation and health risks associated with these foods, which are heavily marketed to children and linked to various chronic diseases. Want More Context? 🔎
Read more